---
title: "IMAC Holdings, Inc. (BACK.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/BACK.US.md"
symbol: "BACK.US"
name: "IMAC Holdings, Inc."
industry: "Biotechnology"
datetime: "2026-05-20T07:26:52.476Z"
locales:
  - [en](https://longbridge.com/en/quote/BACK.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/BACK.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/BACK.US.md)
---

# IMAC Holdings, Inc. (BACK.US)

## Company Overview

IMAC Holdings, Inc., through its subsidiary, Ignite Proteomics LLC, provides proteomic product and precision medicine services based on activated protein analysis for the treatment of cancer in the United States. The company offers a reverse phase protein array (RPPA) platform, which can quantify protein signaling to support oncology clinical treatment decisions and biopharmaceutical drug development. IMAC Holdings, Inc. was founded in 2000 and is based in Franklin, Tennessee.

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Exchange | US Market |
| Website | [imacregeneration.gcs-web.com](https://imacregeneration.gcs-web.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: E
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-19T04:30:14.000Z

**Overall: E (0.82)**

**Industry**: Biotechnology

| Metric | Value |
|--------|-------|
| Industry Ranking | 372 / 386 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: E

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -68.46% |  |
| Net Profit YoY | -96.18% |  |
| P/B Ratio | -0.01 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 187899.63 |  |
| Revenue | 22723.00 |  |

#### Multi Score Score: E

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 130.13% | A |
| Profit Margin | -54786.88% | E |
| Gross Margin | -483.69% | E |
| Revenue YoY | -68.46% | E |
| Net Profit YoY | -96.18% | E |
| Total Assets YoY | -78.87% | E |
| Net Assets YoY | -170.39% | E |
| Cash Flow Margin | 34.28% | D |
| OCF YoY | -68.46% | E |
| Turnover | 0.03 | E |
| Gearing Ratio | 4285.35% | E |

```chart-data:radar
{
  "title": "Longbridge Financial Score - IMAC Holdings, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-68.46%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-96.18%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "-0.01",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "187899.63",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "22723.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "E",
      "indicators": [
        {
          "name": "ROE",
          "value": "130.13%",
          "rating": "A"
        },
        {
          "name": "Profit Margin",
          "value": "-54786.88%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "-483.69%",
          "rating": "E"
        },
        {
          "name": "Revenue YoY",
          "value": "-68.46%",
          "rating": "E"
        },
        {
          "name": "Net Profit YoY",
          "value": "-96.18%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "-78.87%",
          "rating": "E"
        },
        {
          "name": "Net Assets YoY",
          "value": "-170.39%",
          "rating": "E"
        },
        {
          "name": "Cash Flow Margin",
          "value": "34.28%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "-68.46%",
          "rating": "E"
        },
        {
          "name": "Turnover",
          "value": "0.03",
          "rating": "E"
        },
        {
          "name": "Gearing Ratio",
          "value": "4285.35%",
          "rating": "E"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.01 | 69/386 | - | - | - |
| PB | -0.01 | 450/386 | - | - | - |
| PS (TTM) | 7.67 | 150/386 | 10.33 | 5.24 | 3.43 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Kiniksa Pharmaceuticals (KNSA.US) | B | A | A | B | A | A |
| 02 | Arbutus Pharma (ABUS.US) | A | A | A | A | B | A |
| 03 | Rigel Pharma (RIGL.US) | A | A | B | A | B | A |
| 04 | Spero Therap (SPRO.US) | A | A | B | A | B | A |
| 05 | CapForce Inc. (CFOR.US) | B | A | A | A | B | A |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/BACK.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/BACK.US/norm.md)
- [Related News](https://longbridge.com/en/quote/BACK.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/BACK.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**